ILMN Add to watchlist $272.33 4.34 (-1.57%) Last updated: Oct 13, 2026 18:03
52-Week Range
$272.33
$88.00 $272.33 $309.35

Fundamentals Overview

Illumina Inc is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 50.3 PEG 4.18 P/B 9.65 P/S 9.24

Profitability

ROE 31.08% Net margin 18.4%

Risk (Beta)

1.43 — higher vol

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Sell — 75% confidence Risk: High Volatility — Beta 1.43. Consider smaller position size due to higher beta.

Pressures (Sell):

P/E 50.3 (premium) · PEG 4.18 · P/S 9.24 (elevated) · Volume below average · Beta 1.43 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$41.78B
P/E (TTM)
50.32
EPS (TTM)
N/A
Dividend Yield
N/A
52-Week Range
$88.00 - $309.35
Volume vs Avg
0.28x
28% of avg (Low)
Beta
1.43

About

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cos...
Sector: Healthcare
Headquarters: US
Beta: 1.43 (More volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric Value
Valuation
P/E (TTM) 50.32
PEG (TTM) 4.18
P/B (TTM) 9.65
P/S (TTM) 9.24
Profitability
ROE (TTM) 31.08%
ROA (TTM) 12.68%
Revenue growth (YoY) N/A
Net margin (TTM) 18.36%
Gross margin (TTM) 66.39%
Operating margin (TTM) 19.52%
Debt to equity (TTM) 0.7

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ILMN.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.